Skip to main content
Industry News
Experts debate the benefits, risks of trials based on RWE

An FDA-funded study using real-world evidence to replicate the results of a randomized, controlled clinical trial showed that the approach might be useful, but some experts said trials based on observational data cannot safely replace prospective clinical trials in regulatory or clinical decision-making. Others also said RWE studies are effective for judging drug safety.

Full Story: